August 18, 2022 "Our message is that people should take as many steps as possible throughout the day at any walk pace, trying to work in a brisk walk for part of the day to gain the greatest benefit in lowering their risk of diabetes."
August 16, 2022 With help from the brain training app Lumosity, environmental health scientists found that adult attention spans are significantly lower in the hours and days after exposure to fine particulate matter and wildfire smoke. This finding was especially prominent in the western U.S., where wildfires have been increasing.
August 15, 2022 Hincapie-Castillo assesses COVID-19 dashboards in public schools, Rothenberg is named RTI International's Mentee of the Year and students from biostatistics are honored for research.
August 12, 2022 Gillings faculty have recently completed four GILs, including two from Round 6 of GIL funding and two from the special COVID-19 round of funding. The results of their work have furthered our understanding of energy storage, brain health, environmental exposures, viral transmission, pandemic response and more.
August 8, 2022 Mortality rates from excessively hot nights caused by climate change are predicted to increase up to 60% across three countries by the end of the century, according to a new study that includes climate research from Dr. Yuqiang Zhang at the Gillings School.
August 4, 2022 Brooke Staley, a doctoral candidate in epidemiology at the UNC Gillings School of Global Public Health and former co-chair of the Minority Student Caucus, was selected as one of 38 awardees in the 2022 Ford Foundation Dissertation Fellowship competition.
July 25, 2022 Three UNC-Chapel Hill researchers studied the associations between food insecurity, health-related missed workdays and overnight hospitalizations among working-age adults with Type 2 diabetes.
July 25, 2022 Gillings researchers are recognized for work in pharmacoepidemiology, public health leadership and marine environmental sciences, and a recent alumnus receives outstanding dissertation honors.
July 15, 2022 A clinical trial led by the NIH, with support from the Duke Clinical Research Institute and the Gillings School, recently showed that using infliximab or abatacept to treat adults hospitalized with COVID-19 did not shorten recovery time but did improve survival rates.
July 15, 2022 Medicare patients may be bypassing rural hospitals altogether and traveling longer distances to seek care at urban hospitals, according to new research from Hannah Friedman and Dr. Mark Holmes.
